Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,314,392
-$11,698,552 QoQ
Shares Held
2,066,157
+2.5% QoQ
Ownership
4.00%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86.0907956171772.ToString("F0")%
Shared 0.ToString("F0")%
None 13.909204382822796.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. RGNX ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in RGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,314,392 | 2,066,157 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,012,944 | 2,014,788 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $16,446,182 | 1,704,268 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $8,166,942 | 994,756 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $14,778,296 | 2,066,895 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,485,590 | 2,003,311 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $14,160,195 | 1,349,876 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $13,804,263 | 1,179,852 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $28,230,381 | 1,339,838 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $32,675,853 | 1,820,382 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,286,318 | 381,915 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $7,562,732 | 378,326 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,213,160 | 328,565 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,030,093 | 309,969 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,199,565 | 348,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,516,671 | 506,748 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $13,403,679 | 403,847 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $14,200,528 | 434,267 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,301,255 | 341,156 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,136,265 | 466,828 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $8,953,463 | 262,488 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,263,639 | 182,179 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $8,582,164 | 311,852 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,956,449 | 188,880 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $5,009,184 | 154,700 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||